The IX t h Makassed Medical Congress - American University of Beirut

T h e I X t h M a k a s e d M e d i c a l C o n g r e s s
6. Horstkotte D, Loogen F: The natural history of aortic valve
stenosis. Eur Heart J 1988, 9(Suppl E):57–64.
7. Iivanainen AM, Lindroos M, Tilvis R, et al.: Natural
history of aortic valve stenosis of varying severity in the
elderly. Am J Cardiol 1996, 78:97–101.
8. Chizner MA, Pearle DL, deLeon AC Jr: The natural history
of aortic stenosis in adults. Am Heart J 1980, 99:419–424.
9. Varadarajan P, Kapoor N, Bansal RC, Pai RG: Clinical
profi le and natural history of 453 nonsurgically managed
patients with severe aortic stenosis. Ann Thorac Surg 2006,
82:2111–2115.
10. Iung B, Cachier A, Baron G, et al.: Decision-making in
elderly patients with severe aortic stenosis: why are so many
denied surgery? Eur Heart J 2005, 26:2714–2720.
11. Bouma BJ, van Den Brink RB, van Der Meulen JH, et al.:
To operate or not on elderly patients with aortic stenosis:
the decision and its consequences. Heart 1999, 82:143–148.
12. Pai RG, Kapoor N, Bansal RC, Varadarajan P: Malignant
natural history of asymptomatic severe aortic stenosis:
benefi t of aortic valve replacement. Ann Thorac Surg 2006,
82:2116–2122.
13. Bach DS, Cimino N, Deeb GM: Unoperated patients with
severe aortic stenosis. J Am Coll Cardiol 2007, 50:2018–2019.
14. Cribier A, Eltchaninoff H, Tron C, et al.: Treatment of
calcifi c aortic stenosis with the percutaneous heart valve:
mid-term follow-up from the initial feasibility studies: the
French experience. J Am Coll Cardiol 2006, 47:1214–1223.
15. Grube E, Laborde JC, Gerckens U, et al.: Percutaneous
implantation of the CoreValve self-expanding valve prosthesis
in high-risk patients with aortic valve disease: the Siegburg
fi rst-in-man study. Circulation 2006, 114:1616–1624.
16. Webb JG, Chandavimol M, Thompson CR, et al.: Percutaneous
aortic valve implantation retrograde from the femoral
artery. Circulation 2006, 113:842–850.
17. Vassiliades TA Jr, Block PC, Cohn LH, et al.: The clinical
development of percutaneous heart valve technology. J Thorac
Cardiovasc Surg 2005, 129:970–976.
18. Walther T, Simon P, Dewey T, et al.: Transapical minimally
invasive aortic valve implantation: multicenter experience.
Circulation 2007, 116(11 Suppl):I240–I245.
19. Block PC, Bonhoeffer P: Percutaneous approaches to
valvular heart disease. Curr Cardiol Rep 2005, 7:108–113.
20.• Zajarias A, Cribier AG: Outcomes and safety of percutaneous
aortic valve replacement. J Am Coll Cardiol 2009,
53:1829–1836.
This is a concise review of the current status of TAVI.
21. Webb JG, Altwegg L, Boone RH, et al.: Transcatheter aortic
valve implantation: impact on clinical and valve-related
outcomes. Circulation 2009, 119:3009–3016.
22. Andersen HR, Knudsen LL, Hasenkam JM: Transluminal
implantation of artifi cial heart valves. Description of a new
expandable aortic valve and initial results with implantation
by catheter technique in closed chest pigs. Eur Heart J
1992, 13:704–708.
23. Webb JG, Altwegg L, Masson JB, et al.: A new transcatheter
aortic valve and percutaneous valve delivery system. J Am
Coll Cardiol 2009, 53:1855–1858.
24.•• Webb JG, Pasupati S, Humphries K, et al.: Percutaneous
transarterial aortic valve replacement in selected high-risk
patients with aortic stenosis. Circulation 2007, 116:755–763.
This landmark article describes the balloon-expandable valve.
Transcatheter Aortic Valve Implantation Kapadia and Tuzcu 475
90
25. Lichtenstein SV, Cheung A, Ye J, et al.: Transapical transcatheter
aortic valve implantation in humans: initial clinical
experience. Circulation 2006, 114:591–596.
26. Ye J, Cheung A, Lichtenstein SV, et al.: Six-month outcome
of transapical transcatheter aortic valve implantation in
the initial seven patients. Eur J Cardiothorac Surg 2007,
31:16–21.
27. Walther T, Falk V, Borger MA, et al.: Minimally invasive
transapical beating heart aortic valve implantation—proof
of concept. Eur J Cardiothorac Surg 2007, 31:9–15.
28. Svensson LG, Dewey T, Kapadia S, et al.: United States
feasibility study of transcatheter insertion of a stented
aortic valve by the left ventricular apex. Ann Thorac Surg
2008, 86:46–54; discussion 55.
29. Grube E, Laborde JC, Zickmann B, et al.: First report on
a human percutaneous transluminal implantation of a
self-expanding valve prosthesis for interventional treatment
of aortic valve stenosis. Catheter Cardiovasc Interv 2005,
66:465–469.
30. Grube E, Schuler G, Buellesfeld L, et al.: Percutaneous
aortic valve replacement for severe aortic stenosis in
high-risk patients using the second- and current thirdgeneration
self-expanding CoreValve prosthesis: device
success and 30-day clinical outcome. J Am Coll Cardiol
2007, 50:69–76.
31.• Kapadia SR, Svensson L, Tuzcu EM: Successful percutaneous
management of left main trunk occlusion during
percutaneous aortic valve replacement. Catheter Cardiovasc
Interv 2009, 73:966–972.
This interesting case report sheds light on coronary ostial compromise
after percutaneous AVR.
32. Kodali S: Edward’s valve experience. Presented at the 20th
Annual Transcatheter Cardiovascular Therapeutics Meeting.
Washington, DC; October 12–17, 2008.
33. Webb JG: Vancouver experience. Presented at the 20th
Annual Transcatheter Cardiovascular Therapeutics Meeting.
Washington, DC; October 12–17, 2008.
34. Lefevre T: European experience with balloon expandable
valve. Presented at the 20th Annual Transcatheter Cardiovascular
Therapeutics Meeting. Washington, DC; October
12–17, 2008.
35.• Grube E, Buellesfeld L, Mueller R, et al.: Progress and current
status of percutaneous aortic valve replacement: results
of three device generations of the CoreValve revalving
system. Circ Cardiovasc Interv 2008, 1:167–175.
The authors report on the safety and effi cacy of the self-expanding
CoreValve system.
36. Bleiziffer S, Ruge H, Mazzitelli D, et al.: Results of percutaneous
and transapical transcatheter aortic valve implantation
performed by a surgical team. Eur J Cardiothorac Surg 2009,
35:615–620; discussion 620–621.
37. Tamburino C, Capodanno D, Mul EM, et al.: Procedural
success and 30-day clinical outcomes after percutaneous
aortic valve replacement using current third-generation
self-expanding CoreValve prosthesis. J Invasive Cardiol
2009, 21:93–98.
38. Laborde JC: CoreValve experience. Presented at the 58th
Annual Meeting of the American College of Cardiology.
Orlando, FL; March 29–31, 2009.